BGMS · XBRL financial data

Bio Green Med Solution financial statements, every fiscal year

The same tables from 8 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal years (BGMS's year ends in late December)

In thousands of dollarsDec 31, 2020Dec 31, 2021Dec 31, 2022Mar 11, 2024†Dec 31, 2024†Dec 31, 2025
Revenue————430
Research and development4,75915,47720,274—6,655848
Selling, general and administrative5,8777,4617,382—5,392—
General and administrative————5,3927,717
Total operating expenses—22,38927,656—12,0479,174
Operating income (loss)(10,636)(22,938)(27,656)—(12,004)(8,427)
Interest income4216210—12—
Other income (expense)——1,298—52354
Income tax expense (benefit)(1,236)(3,847)(4,717)—(782)7
Net income (loss)(8,445)(18,887)(21,198)—(11,212)(2,998)
Earnings per share, basic‡ USD per share(51.04)(31.94)(28.36)—(504.30)(6.45)
Earnings per share, diluted‡ USD per share(51.04)(31.94)(28.36)—(504.30)(6.45)
Weighted average shares, basic‡ thousands of shares243598754—22,3142,185
Weighted average shares, diluted‡ thousands of shares243598754—22,3142,185
  • ‡ Per-share figures and share counts are adjusted for the 1-for-14.925373134328357 stock split (December 2023); filings made before it reported them unadjusted.
  • † Share count changed about 157x in the period ending 2024-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
  • † Share count changed about 1/38 in the period ending 2025-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Balance sheet

CSV

Fiscal years (BGMS's year ends in late December)

In thousands of dollarsDec 31, 2020Dec 31, 2021Dec 31, 2022Mar 11, 2024†Dec 31, 2024†Dec 31, 2025
Cash and cash equivalents33,40636,55918,3453,4003,1373,505
Short-term investments5,3264,4774,547———
Accounts receivable—————1,257
Inventory—————1,384
Prepaid and other current assets2,0634,3836,066—537110
Total current assets35,46940,94224,411—3,6746,256
Property and equipment, net1066432—3137
Right-of-use asset1,22730142—512
Goodwill—————1,570
Total assets36,80242,58728,050—4,0948,185
Accounts payable5142,1172,561—4,599617
Accrued liabilities1,9723,1774,950—1,669715
Total current liabilities2,4865,2947,511—6,2681,332
Lease liability, non-current1,05730106—02
Total liabilities3,5435,3247,617—6,2681,343
Accumulated deficit(366,072)(384,959)(405,727)—(439,494)(454,411)
Total stockholders' equity33,25937,26315,939—(2,174)6,842
Total liabilities and equity36,80242,58728,050—4,0948,185
Common shares outstanding (cover page)‡ thousands of shares4766708401,318207,3365,519
  • ‡ Per-share figures and share counts are adjusted for the 1-for-14.925373134328357 stock split (December 2023); filings made before it reported them unadjusted.
  • † Share count changed about 157x in the period ending 2024-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
  • † Share count changed about 1/38 in the period ending 2025-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Cash flows

CSV

Fiscal years (BGMS's year ends in late December)

In thousands of dollarsDec 31, 2020Dec 31, 2021Dec 31, 2022Mar 11, 2024†Dec 31, 2024†Dec 31, 2025
Net income (loss)(8,445)(18,887)(21,198)—(11,212)(2,998)
Stock-based compensation4301,1571,506—5922,334
Depreciation and amortization20—————
Net cash from operating activities(7,934)(18,540)(20,827)—(7,990)(4,770)
Purchases of property and equipment96277———
Net cash from investing activities(96)(27)(7)———
Proceeds from issuing common stock29,7054,000————
Proceeds from issuing equity————6,2096,425
Net cash from financing activities29,50421,7372,998—7,8225,264
Net change in cash21,5213,153(18,214)—(241)368
  • † Share count changed about 157x in the period ending 2024-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
  • † Share count changed about 1/38 in the period ending 2025-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Compare with peers

SIC 5099 and related industry codes, similar size; rows marked “added: same SIC” fill a short list. Each row is the latest quarter reported.

How peers are chosen
  • SIC 5099 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Fewer than three companies fall in that range, so the list adds same-SIC (5099) companies nearest in public float, each marked “added: same SIC”.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingRunwayQuarter
Bio Green Med Solution3,790357*(352)*6.6M10.8 quarters 10-QJun 30, 2026
Greenlane Holdings6,06582(2,268)*694,5442.7 quarters 10-QJun 30, 2026
Alliance Entertainment Holdingadded: same SIC814500*(9,029)*51.0M0.1 quarters 10-KJun 30, 2026
Core & Mainadded: same SIC312,0002,145,00062,000*not reported— 10-QAug 2, 2026
Arculus Systemadded: same SIC2.30(56)*4.1M0.0 quarters 10-QJun 30, 2025
FF Global Holdingsadded: same SICnot reportednot reportednot reportednot reported——
Humitech International Groupadded: same SICnot reportednot reportednot reportednot reported——

Not investment advice. Not affiliated with the U.S. SEC.